DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Cheng A, Kang Y, Lin D , et al.
Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC).
J Clin Oncol 2011;
29 (suppl): Abstract 4000
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.